Showing 37,021 - 37,040 results of 125,008 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((point decrease) OR (mean decrease)) ))', query time: 1.33s Refine Results
  1. 37021
  2. 37022
  3. 37023
  4. 37024
  5. 37025
  6. 37026

    Length of stay following cesarean sections: A population based study in the Friuli Venezia Giulia region (North-Eastern Italy), 2005-2015 by Luca Cegolon (2557609)

    Published 2019
    “…Results were expressed as adjusted regression coefficients (aRC) with 95%CI.</p><p>Results</p><p>Although decreasing over the years (5.0 ± 1.7 days in 2005 vs. 4.4 ± 1.7 days in 2015), the pooled mean LoS in the whole FVG during these 11 years was still 4.7 ± 1.7 days, higher than respective international ED benchmark. …”
  7. 37027
  8. 37028

    Mean of indirect effects per network in relation to recovery biomass of plant–pollinator networks for 2 levels of individual variation and different levels of <i>γ</i><sub>0</sub>.... by Gaurav Baruah (7257587)

    Published 2024
    “…<p>(A) Mean net indirect effects, i.e., <i>β</i>, was below zero across different <i>γ</i><sub>0</sub> and for all matrices with spectral radius less than 1. …”
  9. 37029

    Image_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.tif by Maria Totaro (11665708)

    Published 2021
    “…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I<sup>2 </sup>= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I<sup>2</sup> = 0%, P=0.97). …”
  10. 37030

    Image_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.tif by Maria Totaro (11665708)

    Published 2021
    “…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I<sup>2 </sup>= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I<sup>2</sup> = 0%, P=0.97). …”
  11. 37031

    Table_2_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx by Maria Totaro (11665708)

    Published 2021
    “…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I<sup>2 </sup>= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I<sup>2</sup> = 0%, P=0.97). …”
  12. 37032

    Table_3_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx by Maria Totaro (11665708)

    Published 2021
    “…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I<sup>2 </sup>= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I<sup>2</sup> = 0%, P=0.97). …”
  13. 37033

    Table_3_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx by Maria Totaro (11665708)

    Published 2021
    “…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I<sup>2 </sup>= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I<sup>2</sup> = 0%, P=0.97). …”
  14. 37034

    Table_2_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx by Maria Totaro (11665708)

    Published 2021
    “…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I<sup>2 </sup>= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I<sup>2</sup> = 0%, P=0.97). …”
  15. 37035

    Table_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.doc by Maria Totaro (11665708)

    Published 2021
    “…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I<sup>2 </sup>= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I<sup>2</sup> = 0%, P=0.97). …”
  16. 37036

    Table_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.doc by Maria Totaro (11665708)

    Published 2021
    “…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I<sup>2 </sup>= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I<sup>2</sup> = 0%, P=0.97). …”
  17. 37037

    DataSheet1_Response of soil carbon dioxide efflux to temporal repackaging of rainfall into fewer, larger events in a semiarid grassland.pdf by Matthew C. Roby (13835971)

    Published 2022
    “…We found that repackaging rainfall into few/large events with long dry intervals decreased seasonal cumulative F<sub>s</sub>. Repackaging influenced key aspects of pulses including mean, maximum, and antecedent (day before irrigation) values of soil moisture and F<sub>s</sub> and their rate of decline during drying intervals. …”
  18. 37038

    Image_1_Association between elevated homocysteine levels and obstructive sleep apnea hypopnea syndrome: a systematic review and updated meta-analysis.tif by Jie He (132999)

    Published 2024
    “…CPAP treatment can significantly decrease serum/plasma HCY levels in patients with OSAHS. …”
  19. 37039

    Image_3_Association between elevated homocysteine levels and obstructive sleep apnea hypopnea syndrome: a systematic review and updated meta-analysis.tif by Jie He (132999)

    Published 2024
    “…CPAP treatment can significantly decrease serum/plasma HCY levels in patients with OSAHS. …”
  20. 37040

    Image_2_Association between elevated homocysteine levels and obstructive sleep apnea hypopnea syndrome: a systematic review and updated meta-analysis.tif by Jie He (132999)

    Published 2024
    “…CPAP treatment can significantly decrease serum/plasma HCY levels in patients with OSAHS. …”